Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1277 |
|---|---|
| Identifier | NCT05668013 |
| Trial Title | A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative |
| Interventions | DRUG: TEV-48574 Dose Regimen A|DRUG: TEV-48574 Dose Regiment B |
Participant Information
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-01-11 |
|---|---|
| Primary Completion Date | 2025-12-20 |
| Completion Date | 2031-03-08 |